BABY Insider Trading
BABY | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at BABY provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2015-07-29 03:51 | 2015-07-24 | TRAVERSO KENNETH M | Officer - VP/GM Newborn Care | OPT+S | $45.57 | 18,541 | $844,941 | 101,683 | 0.0% |
| 2015-07-25 03:27 | 2015-07-24 | GUNST ROBERT A | Director | SELL | $45.30 | 4,000 | $181,200 | 50,000 | -7.4% |
| 2015-06-16 03:42 | 2015-06-15 | MOORE WILLIAM M | Director | SELL | $41.30 | 6,000 | $247,800 | 112,402 | -5.1% |
| 2015-06-09 03:42 | 2015-06-08 | HAWKINS JAMES B | Director, Officer - President and CEO | OPT+S | $42.08 | 100,000 | $4,208,000 | 513,798 | 0.0% |
| 2015-06-06 03:31 | 2015-06-03 | CHUNG DONG CHUNE CHRISTOPHER | Officer - Vice President Medical Affairs | OPT+S | $41.01 | 26,000 | $1,066,260 | 129,585 | 0.0% |
| 2015-06-02 03:36 | 2015-05-28 | MOORE WILLIAM M | Director | SELL | $38.29 | 6,000 | $229,740 | 118,402 | -4.8% |
| 2015-05-30 03:30 | 2015-05-27 | LUDLUM KEN | Director | OPT+S | $36.57 | 7,500 | $274,275 | 83,700 | 0.0% |
| 2015-05-29 03:41 | 2015-05-26 | TRAVERSO KENNETH M | Officer - VP/GM Newborn Care | OPT+S | $36.19 | 25,939 | $938,732 | 101,683 | 0.0% |
| 2015-05-16 03:49 | 2015-05-13 | Kennedy Jonathan | Director, Officer - Sr. VP, CFO | OPT+S | $36.25 | 11,459 | $415,389 | 92,727 | 0.0% |
| 2015-05-01 03:56 | 2015-04-28 | TRAVERSO KENNETH M | Officer - VP/GM Newborn Care | OPT+S | $40.80 | 57,233 | $2,334,969 | 0 | 0.0% |
| 2015-04-29 03:48 | 2015-04-24 | Engibous Doris | Director | OPT+S | $42.20 | 15,000 | $633,000 | 10,000 | 0.0% |
| 2015-02-06 04:08 | 2015-02-03 | CHUNG DONG CHUNE CHRISTOPHER | Officer - Vice President Medical Affairs | OPT+S | $36.64 | 40,000 | $1,465,600 | 129,585 | 0.0% |
| 2014-12-12 03:44 | 2014-12-09 | Kennedy Jonathan | Officer - Sr. VP, CFO | OPT+S | $35.67 | 45,833 | $1,634,863 | 80,000 | 0.0% |
| 2014-12-11 04:16 | 2014-12-02 | MOORE WILLIAM M | Director | SELL | $1,110.64 | 7,290 | $8,096,550 | 124,402 | -5.5% |
| 2014-11-05 04:57 | 2014-10-24 | HAWKINS JAMES B | Director, Officer - President & CEO | OPT+S | $34.10 | 18,400 | $627,501 | 435,798 | 0.0% |
| 2014-11-01 02:54 | 2014-10-30 | GUNST ROBERT A | Director | OPT+S | $33.92 | 15,000 | $508,800 | 50,750 | 0.0% |
| 2014-10-30 03:29 | 2014-10-27 | CHUNG DONG CHUNE CHRISTOPHER | Officer - Vice President Medical Affairs | OPT+S | $33.14 | 50,000 | $1,657,015 | 121,585 | 0.0% |
| 2014-10-29 03:56 | 2014-10-24 | HAWKINS JAMES B | Director, Officer - President & CEO | OPT+S | $33.31 | 251,600 | $8,380,293 | 435,431 | 0.0% |
| 2014-10-29 03:36 | 2014-10-24 | TRAVERSO KENNETH M | Officer - VP/GM Newborn Care | OPT+S | $33.33 | 30,000 | $999,900 | 90,183 | 0.0% |
| 2014-09-13 03:50 | 2014-09-10 | MOORE WILLIAM M | Director | SELL | $29.30 | 2,200 | $64,460 | 131,692 | -1.6% |
| 2014-09-11 03:42 | 2014-09-08 | MOORE WILLIAM M | Director | SELL | $29.17 | 5,000 | $145,850 | 133,892 | -3.6% |
| 2014-07-31 21:06 | 2014-07-30 | Noll Austin Francis III | Officer - VP/GM Neurology | OPT+S | $29.42 | 23,500 | $691,370 | 53,000 | 0.0% |
| 2014-03-11 03:14 | 2014-03-06 | TRAVERSO KENNETH M | Officer - VP/GM Newborn Care | SELL | $27.60 | 8,932 | $246,523 | 119,742 | -6.9% |
| 2014-02-19 04:40 | 2014-02-13 | GUNST ROBERT A | Director | OPT+S | $25.00 | 20,000 | $500,000 | 46,750 | 0.0% |
| 2014-02-19 04:34 | 2014-02-13 | CHUNG DONG CHUNE CHRISTOPHER | Officer - Vice President Medical Affairs | OPT+S | $24.88 | 20,000 | $497,600 | 127,972 | 0.0% |
| 2014-02-14 03:45 | 2014-02-11 | HAWKINS JAMES B | Director, Officer - President & CEO | OPT+S | $24.77 | 96,046 | $2,378,790 | 468,844 | 0.0% |
| 2014-02-05 04:22 | 2014-01-31 | Engibous Doris | Director | OPT+S | $25.59 | 20,000 | $511,800 | 6,000 | 0.0% |
| 2014-02-05 04:20 | 2014-01-31 | HAWKINS JAMES B | Director, Officer - President & CEO | OPT+S | $25.93 | 16,910 | $438,444 | 468,844 | 0.0% |
| 2013-12-05 04:25 | 2013-12-02 | HAWKINS JAMES B | Director, Officer - President & CEO | OPT+S | $22.58 | 206,878 | $4,672,257 | 413,844 | 0.0% |
| 2013-11-30 03:24 | 2013-11-26 | CHUNG DONG CHUNE CHRISTOPHER | Officer - Vice President Medical Affairs | OPT+S | $21.81 | 27,159 | $592,338 | 120,972 | 0.0% |
| 2013-11-19 03:43 | 2013-11-14 | MOORE WILLIAM M | Director | OPT+S | $22.01 | 10,000 | $220,114 | 44,892 | 0.0% |
| 2013-11-16 04:05 | 2013-11-12 | CHUNG DONG CHUNE CHRISTOPHER | Officer - VP Medical Affairs, QA/RA | OPT+S | $21.17 | 22,841 | $483,544 | 120,972 | 0.0% |
| 2013-10-31 00:27 | 2013-10-28 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | OPT+S | $19.54 | 25,000 | $488,600 | 122,201 | 0.0% |
| 2013-09-18 03:37 | 2013-09-12 | Engibous Doris | Director | OPT+S | $13.53 | 33,750 | $456,638 | 6,000 | 0.0% |
| 2013-09-13 03:09 | 2013-09-10 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | SELL | $13.89 | 4,225 | $58,684 | 104,029 | -3.9% |
| 2013-08-22 03:33 | 2013-08-19 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | SELL | $12.78 | 5,818 | $74,354 | 108,254 | -5.1% |
| 2013-08-22 03:33 | 2013-08-19 | CHUNG DONG CHUNE CHRISTOPHER | Officer - VP Medical Affairs, QA/RA | SELL | $12.78 | 5,818 | $74,354 | 120,972 | -4.6% |
| 2013-08-22 03:33 | 2013-08-19 | HAWKINS JAMES B | Director, Officer - President and CEO | SELL | $12.78 | 22,190 | $283,588 | 413,211 | -5.1% |
| 2013-06-08 02:35 | 2013-06-05 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | OPT+S | $14.30 | 22,682 | $324,353 | 122,244 | 0.0% |
| 2013-06-06 03:46 | 2013-06-03 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | OPT+S | $14.50 | 7,318 | $106,111 | 122,244 | 0.0% |
| 2013-05-31 02:50 | 2013-05-28 | MURPHY STEVEN J | Officer - Vice President Finance | OPT+S | $14.42 | 10,000 | $144,200 | 113,292 | 0.0% |
| 2013-03-15 00:41 | 2013-03-13 | MURPHY STEVEN J | Officer - Vice President Finance and CFO | SELL | $13.31 | 10,000 | $133,100 | 87,118 | -10.3% |
| 2013-03-15 00:37 | 2013-03-12 | GUNST ROBERT A | Director | BUY | $13.40 | 5,000 | $67,000 | 30,750 | +19.4% |
| 2013-02-22 04:32 | 2013-02-19 | Buhler John T | Officer - President and COO | SELL | $11.95 | 11,886 | $142,038 | 100,610 | -10.6% |
| 2012-12-14 04:53 | 2012-12-11 | MINCE WILLIAM L | Officer - VP North American Operations | SELL | $10.49 | 20,128 | $211,227 | 67,162 | -23.1% |
| 2012-12-01 05:20 | 2012-11-30 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | OPT+S | $11.42 | 26,157 | $298,713 | 95,472 | 0.0% |
| 2012-11-29 00:55 | 2012-11-27 | CHUNG DONG CHUNE CHRISTOPHER | Officer - VP Medical Affairs, QA/RA | SELL | $11.37 | 25,000 | $284,250 | 68,790 | -26.7% |
| 2012-11-29 00:54 | 2012-11-26 | GUNST ROBERT A | Director | BUY | $11.66 | 10,000 | $116,560 | 25,750 | +63.5% |
| 2012-11-14 04:10 | 2012-11-09 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | OPT+S | $11.19 | 49,885 | $558,213 | 99,003 | 0.0% |
| 2012-11-13 17:09 | 2012-11-09 | TRAVERSO KENNETH M | Officer - VP Marketing and Sales | OPT+S | $11.19 | 49,885 | $558,213 | 125,160 | 0.0% |
How to Interpret $BABY Trades
Not every insider transaction in BABY is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BABY shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for BABY
Insider activity data for BABY is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BABY, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.